Johnson & Jonson reported its orthopedics line had a 1.2 percent increase in sales for the third quarter.
Five things to know:
1. Worldwide orthopedics sales hit $2.1 billion, a 1.2 percent increase compared to the same period last year. Both U.S. and international sales were up 1.2 percent, to $1.3 billion and $837 million, respectively.
2. U.S. knee sales were down 2.7 percent to $209 million, but international sales jumped nearly 8 percent to $136 million. Overall knee sales for the quarter were $344 million, a 1.2 percent increase.
3. Spine and other sales were down nearly 1 percent worldwide to $778 million. In the U.S., spine and other sales were relatively flat at $472 million, but international sales were down 2 percent to $306 million.
4. Hip sales in the U.S. were up 1.1 percent to $204 million while international sales were up 2.7 percent to $133 million. Overall hip sales increased 1.7 percent to $336 million.
5. Trauma sales in the U.S. were up 5.1 percent to $415 million while international sales were up 1 percent to $262 million. Overall trauma sales increased 3.5 percent to $677 million.